Skip to content

Tooth Mousse and Fluoride in Dentin Hypersensitivity Treatment

Combined Tooth Mousse and Fluoride Varnish in Dentin Hypersensitivity Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00926484
Enrollment
30
Registered
2009-06-23
Start date
2007-01-31
Completion date
2008-06-30
Last updated
2009-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Hypersensitivity

Keywords

Dentin hypersensitivity, Tooth Mousse, fluoride varnish

Brief summary

GC Tooth Mousse, a complex containing amorphous calcium phosphate (ACP) and casein phosphopeptide (CPP), is recommended in dentin hypersensitivity reduction due to its ability to block opened dentinal tubules. It acts synergistically with fluorine in slowing caries progression. Whether CPP-ACP can act synergistically with fluorine in the dentin hypersensitivity treatment is unknown. The aim of this study was to assess the effect of CPP-ACP combined with fluoride varnish in cervical dentin hypersensitivity treatment.

Interventions

None listed

Sponsors

National Natural Science Foundation of China
CollaboratorOTHER_GOV
Huazhong University of Science and Technology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
26 Years to 66 Years
Healthy volunteers
No

Inclusion criteria

* subjects with a minimum of three cervical hypersensitive teeth at both sides of the dental arch

Exclusion criteria

* dentin hypersensitivity caused by caries lesions * fracture of restoration * chipped teeth * marginal gaps * post-operative sensitivity * cracked-tooth syndrome, and which were confirmed by periapical radiographs and teeth with cervical fillings

Design outcomes

Primary

MeasureTime frame
ANOVAJune 2008

Secondary

MeasureTime frame
T-testJune 2008

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026